LIVE MARKET TRACKER :   BSE SENSEX   31599.76      |    NSE NIFTY 9871.50    
GLOBAL MARKETS :  NASDAQ 6370.5898   -0.8765%    |    FSI London 7301.87   +0.01%    |    NIKKEI Japan 20330.19   -0.33%
  USD GBP EUR CAD AUD INR
USD - 0.7441 0.8481 1.2368 1.2674 65.6000
GBP 1.3443 - 1.1399 1.6622 1.7026 88.1669
EUR 1.1798 0.8782 - 1.4588 1.4943 77.3502
CAD 0.8091 0.6022 0.6856 - 1.0248 53.0380
AUD 0.7894 0.5875 0.6694 0.9763 - 51.7750
INR 0.0153 0.0114 0.0129 0.0189 0.0194 -
Indian-Commodity  :  Top News  :  Maruti Suzuki reports 31.1% rise in September sales

Maruti Suzuki reports 31.1% rise in September sales (01-Oct-2016)

Maruti Suzuki India, country's largest car maker, has sold at 1, 49,143 units in the month of September 2016 and has registered a rise of 31.1% in its total car sales (Domestic + Export), as against 1, 13,759 units in September 2015. The company's domestic sales for the month of September 2016 being 1, 37,277 units has increased by 29.4% when compared to 1, 06,083 units for the same month last year.

Of the total, the company has sold 1, 05,236 units of its passenger cars in September 2016, up by 19.7% as against 87,916 units in September 2015. The company has sold 13,618 units of its van in September 2016, up by 15.1% as against 11,836 units in September 2015. Further, the company has sold 18,423 units of its utility vehicle in September 2016, up by 191% as against 6,331 units in September 2015.

Furthermore, the company's exports have increased to11, 822 units in September 2016 from 7,676 units in September 2015, showing a 54% increase.


Top News Today
Jaiprakash Associates gets nod to raise up to Rs 2,000 crore
(26-Sep-2017)

Jaiprakash Associates gets nod to raise up to Rs 2,000 croreJaiprakash Associates has received its shareholders' approval to raise up to Rs 2,000 crore through sale of securities. The special resolution was approved by the shareholders at the company's annual general......click on news to read complete article.

Panacea Biotec planning to raise Rs 250 crore
(26-Sep-2017)

Panacea Biotec planning to raise Rs 250 crorePanacea Biotec is planning to raise Rs 250 crore by way of issue of equity shares and/or other securities. In this regards, the company is conducting Postal Ballot for obtaining approval of members for......click on news to read complete article.

Novartis India gets nod for Rs 231.15 crore buyback plan
(26-Sep-2017)

Novartis India gets nod for Rs 231.15 crore buyback planNovartis India has received an approval for buyback of up to 34.5 lakh shares, accounting for about 12.26% of the existing paid up capital of the company, for up to Rs 231.15 crore. The company's board......click on news to read complete article.

International Stock News
Asian markets trade mostly lower in early deals on Tuesday
(26-Sep-2017)

Asian markets trade mostly lower in early deals on TuesdayMost of the Asian equity benchmarks are trading down in the early deals on Tuesday, following declines on Wall Street overnight, as the war of words between North Korea and the US escalated. Meanwhile,......click on news to read complete article.

US markets closed lower on North Korea's threat
(26-Sep-2017)

US markets closed lower on North KoreaThe US markets closed lower on Monday, on the back of a fresh flare up in tensions between the US and North Korea and a sharp decline in technology shares. North Korean foreign minister Ri Yong Ho, speaking......click on news to read complete article.

Asian markets trade mostly lower in early deals on Monday
(25-Sep-2017)

Asian markets trade mostly lower in early deals on MondayMost of the Asian equity benchmarks are trading down in the early deals on Monday, following the lackluster cues from Wall Street and concerns about China's economy. Investors digested election results......click on news to read complete article.

 

     
  
Recent Top News News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.